tetradecanoylphorbol acetate has been researched along with myelin oligodendrocyte glycoprotein (35-55) in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ben, LH; Cravens, PD; Gocke, AR; Hussain, RZ; Liu, Y; Lovett-Racke, AE; McTigue, DM; Peng, H; Puttaparthi, K; Racke, MK; Wei, P; Winger, R; Yang, Y | 1 |
1 other study(ies) available for tetradecanoylphorbol acetate and myelin oligodendrocyte glycoprotein (35-55)
Article | Year |
---|---|
Silencing Nogo-A promotes functional recovery in demyelinating disease.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; GAP-43 Protein; Gene Expression Regulation; Glycoproteins; Interferon-gamma; Interleukin-10; Lymphocytes; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myelin Basic Protein; Myelin Proteins; Myelin-Oligodendrocyte Glycoprotein; Neuroblastoma; Nogo Proteins; Peptide Fragments; RNA, Small Interfering; Spinal Cord; Tetradecanoylphorbol Acetate; Transfection | 2010 |